Regal Assets Analytics

SanaCurrents

FDA Approves Biocryst (BCRX) Drug For HAE; Sanacurrents Closing Out Coverage

By |2020-12-07T11:59:13-05:00December 7th, 2020|Categories: Bill Langbein, SanaCurrents, SanaCurrents Updates|Tags: |

After the markets closed on Thursday, December 3, BioCryst Pharmaceuticals [...]

Keeping an Eye on ALLO, SYRS, PTGX, AUTL, and IMRA in Light of Biotech Catalysts; Disclosure Updates

By |2020-12-07T11:59:23-05:00December 7th, 2020|Categories: Bill Langbein, SanaCurrents, SanaCurrents Updates|Tags: , , , , |

Clinical data findings related to five SanaCurrents catalysts will be [...]